Clinical Trials Browser

Completed × Nasopharyngeal Carcinoma × apatinib × Clear all

NCT04350190 2023-01-13

Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma